The Leukemia & Lymphoma Society is a voluntary health organization that funds blood cancer research, education and patient services. As the world’s largest voluntary organization of this sort, they work tirelessly to cure leukemia, lymphoma, Hodgkin’s disease and melanoma. Furthermore, they work to improve patient quality of life both for the patient and for his or her family.
The Leukemia & Lymphoma Society has information specialists who can help cancer sufferers with the challenges and questions of their diagnosis. In addition, they offer healthcare professionals who are involved in patient care and can provide cancer patients with information and support.
The NIR Group, with managing partner and head portfolio manager Corey Ribotsky, is committed to lending its financial support to the Leukemia & Lymphoma Society.